Director of the Centre for Hypertrophic Cardiomyopathy and Valvular Heart Disease at  Policlinico di Monza

Name: Paolo Ferrazzi
Date of birth: 16th August 1947
Place of birth:  Venice

Schooling

1972 Degree in Medicine and Surgery, l'Università degli Studi di Roma, grade awarded 110/110 with honours.
1973 Medical and Surgical license
1975 Specialisation  in  Pediatric Surgery, l'Università degli Studi di Ferrara, grade awarded  70/70.
1978 Specialisation in Cardiac Surgery, l'Università degli Studi di Bari, grade awarded  50/50.
1980 Assistant Cardiac Surgeon license
1985 Head physician license Cardiac surgery
2002 Trainer in  Healthcare facility director courses
2008 Training course: Hospital Departments organised by the Business Management Institute of Università Bocconi

Career

July  2013-present:  Director of the Centre for Hypertrophic cardiomyopathy and Valvular Heart Disease at  Policlinico di Monza
2009 -present:  Director of International Heart School – Fondazione di Bergamo per la Formazione   Medica continua – ONLUS (non-profit foundation for medical training)
2000 - June 2013: Director of Clinical Cardiac Research Dept. Ospedaliera Ospedali Riuniti di Bergamo
1999 - June 2013: Director Cardiac Surgery Unit  dell'Azienda Ospedaliera Ospedali Riuniti di Bergamo
1995-1999: Head Physician Cardiac Surgery  in adult patients at Stabilimento di Massa (Ospedale G. Pasquinucci)  of Azienda Ospedaliera CREAS-IFC del CNR:
1991-1995: Director of Mitral Valves Programme in his unit.
1988-1995: Director and Coordinator of  the Programme for Inpatient Ventricular Mechanical  Care in his unit.
1987-1995: Assistant/co-director Cardiac Surgery Unit  Ospedali Riuniti di Bergamo.
1985-1995: Director and Coordinator of  the Transplant Programme in his unit.
1984: Special Fellow  l'University of Alabama a Birmingham (USA),
directed by Dr J.W. Kirklin. 
1977-1986: Director of Unit of Post-surgery infections.
1973-1987: Assistant  Cardiac Surgery Unit  Ospedali Riuniti di Bergamo.
Honours and Awards
2007: Knighted by the President of The Italian Republic

Clinical-Surgical Activity

Clinical Surgery: 
Dr Ferrazzi has performed more than 10.000 open heart operations, including heart transplants in adults and children.

Pediatric Cardiac Surgery:
Congenital defect repair in children, including heart transplant.

Coronary Artery Surgery:
Standard Surgical treatment of coronary artery disease and chronic ischemic left ventricular dysfunction and aneurysmectomy as an alternative to transplant.

Valvular Surgery:
Aortic and mitral valve prosthetic replacement, reconstruction of mitralic and aortic valve.

Heart Failure Surgery:
Heart Transplants

Mechanical Circulatory Assistance:
Implantation of mechanical ventricular assistance devices (continuous-flow, pneumatic and electromechanical) in pediatric and adult  patients before transplant  and in cardiac function recovery.
 
Surgical Alternatives to Transplant:
Ventriculotomy  and ventricular  remodeling in patients who were not suitable candidates to transplant.

Surgical Treatment of Hypertophic Cardiomyopathy:
Extensive Myomectomy with correction of subvalvular mitralic apparatus malformations.


Scientific Activity

1. Research
2007- 2009 Director of the Project TELETHON GGP7235 “Dissection of genetic mechanisms of left ventricular outflow tract obstruction defects by high-resolution array-CGH”, coordinated by Prof O. Zuffardi, Pavia

2008 Organiser of  Workshop “Myectomy in Obstructive Hyperthrophic Cardiomyopathy:surgical indication and post-operative care “ USC di Cardiochirurgia A.O. Ospedali Riuniti di Bergamo

2005 - 2006 Clinical and Surgical Consultant, Director of Research Organisation NewCorTec for the development and the performance of ventricular assistance

2004 - 2006 Principal Investigator Syntax Trial

2003 - present Principal Investigator StichTrial – NIH (surgical treatment ischemic cardiomyopathy)

2000 - present  Director of the research project (patent PCT/IT01/00156) Endoventricular device for the treatment and correction of cardiomyopathy

2001- 2004 Director of the Project Fondazione Cariplo: “Role of genetic predisposition factors in the most frequent complications after myocardiac revascularization surgery”

News dal Gruppo

Ecco le piu’ recenti tecniche a confronto

La patologia emorroidaria affligge circa 4 italiani su 10, si manifesta in diverse forme, da lievi a gravi, ma in ogni caso è un...

Sclerosimultipla: il policlinico diventacentro di riferimento

Il Policlinico di Monza è stato recentemente inserito nell’elenco dei Centri di riferimento, della Regione...

Le novità del prof. Biggi e della sua équipe di Monza

Ogni anno, in Italia, vengono impiantate circa 80.000 artroprotesi d’anca e 60.000 di ginocchio, ad indicare...